Feedback (LON:FDBK) Share Price Passes Above 50 Day Moving Average – Should You Sell?

Feedback plc (LON:FDBK) shares passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 10.29 and traded as high as GBX 11.15. Feedback shares last traded at GBX 11, with a volume of 138,000 shares changing hands.

Feedback Stock Performance

The company has a 50 day simple moving average of GBX 10.29 and a 200 day simple moving average of GBX 10.76. The stock has a market cap of £4.82 million, a P/E ratio of -0.43 and a beta of 0.77.

Insider Buying and Selling at Feedback

In related news, insider Emma Oswick (Stuart) purchased 60,459 shares of the stock in a transaction on Tuesday, December 23rd. The shares were purchased at an average cost of GBX 8 per share, with a total value of £4,836.72. Also, insider Tom Oakley acquired 60,904 shares of the stock in a transaction on Tuesday, December 23rd. The shares were purchased at an average price of GBX 8 per share, for a total transaction of £4,872.32. Corporate insiders own 7.98% of the company’s stock.

Feedback Company Profile

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.